News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Robert Z. Orlowski: Honored to be named among the inaugural group of Highly Ranked Scholars
Photo of Robert Z. Orlowski from faculty.mdanderson.org
May 8, 2024, 12:49

Robert Z. Orlowski: Honored to be named among the inaugural group of Highly Ranked Scholars

Robert Z. Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared a post on X:

“Honored to be named among the inaugural group of Highly Ranked Scholars by ScholarGPS.”

Robert Z. Orlowski

Read further.
Source: Robert Z. Orlowski/X

cancer MD Anderson Cancer Center OncoDaily Oncology Robert Z. Orlowski
Special Coverage
Science
Feb 21, 2025, 13:51
Aaron Sverdlov: Identifying common pathways for doxorubicin and carfilzomib-induced cardiotoxicities
Blog
Feb 21, 2025, 13:40
Breaking barriers: ensuring equal cancer care access for diverse communities - SPCC
Blog
Feb 21, 2025, 13:29
Sana Al Sukhun: Enjoyed joining Emirates Oncology Society's SABCS
Blog
Feb 21, 2025, 13:28
Targeted protein degradation is changing the landscape of cancer treatment - The ICR
Blog
Feb 21, 2025, 13:07
Kelley Wood: What is the cost of inactivity in oncology care?
Blog
Feb 21, 2025, 13:06
Marta B. Afonso: A reminder that raising awareness can shake things up
Blog
Feb 21, 2025, 13:03
Dégi László Csaba: European Cancer Summit Report 2024 is here!
Blog
Feb 21, 2025, 13:00
Susanna Greer: "What If" to Reality - A New Dawn in Lung Cancer Detection
Insight
Feb 21, 2025, 12:53
Nina Niu Sanford: My take on protons and approach to discussing with patients
Blog
Feb 21, 2025, 12:46
Eric Bouffet: Amazing Webinar with the African Francophone Group of Pediatric Oncology
Blog
Feb 21, 2025, 12:41
Aleix Prat takes on the role of Chair of the Advisory Board at ONA Therapeutics
Blog
Feb 21, 2025, 12:39
Clinical Trials in Europe: Key Trends and Issues - Lung Cancer Europe